Chinese Drugmaker InnoCare Gets $160M Investment Led By PE Firm Loyal Valley Capital

Login to View

Chinese biotech company Beijing InnoCare Pharma Tech Co. (InnoCare) has secured a US$160 million new round of financing led by the country’s private equity investment management firm Loyal Valley Capital, according to a statement released on InnoCare’s website on Friday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in